The place of thalidomide in the treatment of multiple myeloma
Thalidomide represents the first attempt in multiple myeloma (MM) patients to overcome resistance to chemotherapy through a biological agent. The exciting results reported in the first study by Singhal et al. in 1999 [1] led to several other studies which aimed to evaluate its efficacy in different...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2011-12-01
|
| Seri Bilgileri: | Oncology Reviews |
| Konular: | |
| Online Erişim: | http://oncologyreviews.org/index.php/or/article/view/157 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|